Excision repair cross-complementation group 1

Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer

H. Gao, Ge, R. C., Liu, H. Y., Wang, Y., and Yan, S., Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer, vol. 13, pp. 8997-9004, 2014.

We conducted a cohort study to investigate the role of 3 single-nucleotide polymorphisms of the excision repair cross-complementation group 1 (ERCC1) gene on the response to chemotherapy and clinical outcomes of non-small cell lung cancer (NSCLC). A total of 163 patients with newly diagnosed and histopathologically confirmed primary NSCLC were examined in our study and were followed up until December 2012. ERCC1 rs11615, rs3212986, and rs2298881 were selected and genotyped.

Subscribe to Excision repair cross-complementation group 1